CureVac NV CVAC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:41 PM EST
11.67quote price arrow down-0.01 (-0.09%)
Volume
1,455
Close
11.68quote price arrow down-0.11 (-0.93%)
Volume
599,524
52 week range
5.63 - 20.50
Loading...
  • Open11.44
  • Day High11.91
  • Day Low11.42
  • Prev Close11.79
  • 52 Week High20.50
  • 52 Week High Date02/02/22
  • 52 Week Low5.63
  • 52 Week Low Date12/27/22

Key Stats

  • Market Cap2.223B
  • Shares Out190.28M
  • 10 Day Average Volume1.42M
  • Dividend-
  • Dividend Yield-
  • Beta2.49
  • YTD % Change93.7

KEY STATS

  • Open11.44
  • Day High11.91
  • Day Low11.42
  • Prev Close11.79
  • 52 Week High20.50
  • 52 Week High Date02/02/22
  • 52 Week Low5.63
  • 52 Week Low Date12/27/22
  • Market Cap2.223B
  • Shares Out190.28M
  • 10 Day Average Volume1.42M
  • Dividend-
  • Dividend Yield-
  • Beta2.49
  • YTD % Change93.7

RATIOS/PROFITABILITY

  • EPS (TTM)-0.64
  • P/E (TTM)-18.35
  • Fwd P/E (NTM)-10.99
  • EBITDA (TTM)-98.513M
  • ROE (TTM)-18.51%
  • Revenue (TTM)106.545M
  • Gross Margin (TTM)-79.47%
  • Net Margin (TTM)-126.02%
  • Debt To Equity (MRQ)6.60%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Franz-Werner Haas LL.D.
Chief Executive Officer, Chief Operating Officer, Member of the Management Board
Malte Greune Ph.D.
Chief Operating Officer, Member of the Management Board
Pierre Kemula
Chief Financial Officer, Member of the Management Board
Address
Friedrich-Miescher-Str. 15
Tuebingen
72076
Germany

Top Peers

SYMBOLLASTCHG%CHG
KYMR
Kymera Therapeutics Inc
38.75+2.16+5.90%
KRYS
Krystal Biotech Inc
80.58-1.13-1.38%
CLDX
Celldex Therapeutics Inc
44.98+1.27+2.91%
TGTX
TG Therapeutics Inc
17.97+1.20+7.16%
FGEN
FibroGen Inc
24.85+0.46+1.89%